Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt
· Delayed Price · Currency is EGP 800.38
+3.14 (0.39%)
At close: Mar 9, 2026
EGX:AXPH Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 245.69 | 285.8 | 150.04 | 90.51 | 153.75 | 52.12 | Upgrade
|
| Cash & Short-Term Investments | 245.69 | 285.8 | 150.04 | 90.51 | 153.75 | 52.12 | Upgrade
|
| Cash Growth | 27.61% | 90.49% | 65.77% | -41.13% | 194.98% | -68.72% | Upgrade
|
| Accounts Receivable | 319.08 | 120.65 | 62.7 | 66.91 | 113.61 | 106.2 | Upgrade
|
| Other Receivables | 59.65 | 95.44 | 87.2 | 28.14 | 22.65 | 27.34 | Upgrade
|
| Receivables | 449.08 | 265.29 | 186.19 | 144.18 | 168.13 | 166.16 | Upgrade
|
| Inventory | 606.67 | 607.36 | 522.51 | 345.41 | 271.51 | 307.64 | Upgrade
|
| Prepaid Expenses | 0.19 | 0.19 | 0.19 | 0.27 | 0.36 | 0.05 | Upgrade
|
| Restricted Cash | - | - | - | - | 0 | 0.86 | Upgrade
|
| Other Current Assets | - | - | -0 | -0 | 0 | -0 | Upgrade
|
| Total Current Assets | 1,302 | 1,159 | 858.93 | 580.36 | 593.76 | 526.82 | Upgrade
|
| Property, Plant & Equipment | 380.75 | 366 | 379.71 | 340.24 | 279.06 | 264.29 | Upgrade
|
| Long-Term Investments | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | Upgrade
|
| Other Long-Term Assets | - | - | - | -0 | - | - | Upgrade
|
| Total Assets | 1,685 | 1,527 | 1,241 | 922.99 | 875.21 | 793.49 | Upgrade
|
| Accounts Payable | 420.22 | 309.36 | 277.85 | 139.28 | 160.86 | 92.14 | Upgrade
|
| Accrued Expenses | 16.97 | 6.07 | 5.17 | 4.16 | 4.32 | 6.45 | Upgrade
|
| Short-Term Debt | 3.33 | 4.08 | 0.81 | 12.03 | 9.11 | 1.77 | Upgrade
|
| Current Unearned Revenue | 0.56 | 0.61 | 0.24 | 1.25 | - | - | Upgrade
|
| Other Current Liabilities | 291.48 | 203.67 | 152.4 | 91.7 | 78.13 | 99.48 | Upgrade
|
| Total Current Liabilities | 732.57 | 523.8 | 436.47 | 248.42 | 252.43 | 199.83 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 8.95 | 8.95 | 9.57 | 14.44 | 10.18 | 7.46 | Upgrade
|
| Total Liabilities | 741.52 | 532.75 | 446.04 | 262.85 | 262.6 | 207.29 | Upgrade
|
| Common Stock | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
| Retained Earnings | 885.95 | 936.98 | 738.24 | 604.42 | 494.73 | 530.88 | Upgrade
|
| Comprehensive Income & Other | 7.3 | 7.3 | 6.74 | 5.72 | 67.87 | 5.32 | Upgrade
|
| Shareholders' Equity | 943.26 | 994.28 | 794.98 | 660.14 | 612.6 | 586.2 | Upgrade
|
| Total Liabilities & Equity | 1,685 | 1,527 | 1,241 | 922.99 | 875.21 | 793.49 | Upgrade
|
| Total Debt | 3.33 | 4.08 | 0.81 | 12.03 | 9.11 | 1.77 | Upgrade
|
| Net Cash (Debt) | 242.36 | 281.72 | 149.22 | 78.48 | 144.63 | 50.35 | Upgrade
|
| Net Cash Growth | 29.35% | 88.79% | 90.14% | -45.74% | 187.27% | -68.29% | Upgrade
|
| Net Cash Per Share | 48.47 | 56.34 | 29.84 | 15.70 | 28.93 | 10.07 | Upgrade
|
| Filing Date Shares Outstanding | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Total Common Shares Outstanding | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Working Capital | 569.07 | 634.85 | 422.46 | 331.94 | 341.33 | 326.99 | Upgrade
|
| Book Value Per Share | 188.65 | 198.86 | 159.00 | 132.03 | 122.52 | 117.24 | Upgrade
|
| Tangible Book Value | 943.26 | 994.28 | 794.98 | 660.14 | 612.6 | 586.2 | Upgrade
|
| Tangible Book Value Per Share | 188.65 | 198.86 | 159.00 | 132.03 | 122.52 | 117.24 | Upgrade
|
| Land | 0.08 | 0.08 | - | - | - | 0.08 | Upgrade
|
| Buildings | 197.43 | 197.53 | - | - | - | 38.75 | Upgrade
|
| Machinery | 485.23 | 479.43 | - | - | - | 306.41 | Upgrade
|
| Construction In Progress | 70.1 | 38.08 | - | - | - | 134.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.